GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WDB coco Co Ltd (TSE:7079) » Definitions » Total Liabilities

WDB coco Co (TSE:7079) Total Liabilities : 円856 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is WDB coco Co Total Liabilities?

WDB coco Co's Total Liabilities for the quarter that ended in Dec. 2023 was 円856 Mil.

WDB coco Co's quarterly Total Liabilities increased from Jun. 2023 (円723.02 Mil) to Sep. 2023 (円844.46 Mil) and increased from Sep. 2023 (円844.46 Mil) to Dec. 2023 (円855.73 Mil).

WDB coco Co's annual Total Liabilities increased from Mar. 2021 (円564.02 Mil) to Mar. 2022 (円985.59 Mil) but then declined from Mar. 2022 (円985.59 Mil) to Mar. 2023 (円858.14 Mil).


WDB coco Co Total Liabilities Historical Data

The historical data trend for WDB coco Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WDB coco Co Total Liabilities Chart

WDB coco Co Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Total Liabilities
Get a 7-Day Free Trial 363.87 536.68 564.02 985.59 858.14

WDB coco Co Quarterly Data
Mar18 Mar19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 778.64 858.14 723.02 844.46 855.73

WDB coco Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

WDB coco Co's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=719.116+(13.028+37.479
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+88.519)
=858

Total Liabilities=Total Assets (A: Mar. 2023 )-Total Equity (A: Mar. 2023 )
=3660.927-2802.785
=858

WDB coco Co's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=690.625+(0+60.062
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+105.045)
=856

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=4135.661-3279.929
=856

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


WDB coco Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of WDB coco Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


WDB coco Co (TSE:7079) Business Description

Traded in Other Exchanges
N/A
Address
1-8-11 Harumi, Chuo-ku, Triton Square Y 27th Floor, Tokyo, JPN, 104-6127
WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.

WDB coco Co (TSE:7079) Headlines

No Headlines